Rituximab and dose-dense chemotherapy in primary testicular lymphoma

Clinical Lymphoma and Myeloma

Volumn 9, Issue 5, 2009, Pages 386-389

  Avilés, Agustin ^a   Nambo, M Jesús ^a   Cleto, Sergio ^a   Neri, Natividad ^a   Huerta Guzmán, Judith ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

Author keywords

CEOP14; Epirubicin; Non Hodgkin lymphoma; Non Hodgkin's lymphoma

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; EPIRUBICIN; FOLINIC ACID; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PREDNISONE; RITUXIMAB; VINCRISTINE;

ABDOMINAL PAIN; ADJUVANT THERAPY; ADULT; AGED; ANEMIA; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; DRUG TOLERABILITY; GRANULOCYTOPENIA; HUMAN; INFECTION; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUROTOXICITY; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; PRIMARY TESTICULAR LYMPHOMA; PRIMARY TUMOR; PROGNOSIS; PROPHYLAXIS; TESTIS TUMOR; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 70350666366     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.3816/CLM.2009.n.075     Document Type: Article

References (20)

1. Vitolo U, Ferreri AJM, Zucca E. Primary testicular lymphoma. Crit Rev Oncol Hematol 2008; 65:183-189.
2. Booman M, Dowles J, Kegaeur MC, et al. From brain to testis. Immune escape and clonal selection in B-cell lymphoma with selective out growth in two immune sanctuaries. Haematologica 2007; 92:e-69.
3. Vural F, Cagirgan S, Saydam G, et al. Primary testicular lymphoma. J Natl Med Assoc 2007; 99:1277-1282.
4. Park BB, Kim JG, Suhn S, et al. Considerations of aggressive therapeutic strategies for primary testicular lymphoma. Am J Hematol 2007; 82:840-844.
5. Al-Abbadi MA, Hattab EM, Tarawneh M, et al. Primary testicular and paratesticular lymphoma. Arch Pathol Lab Med 2006 131:10040-10046.
6. Avilés A, Neri N, Huerta-Guzmán JH, et al. Testicular lymphoma: Organ specific treatment did not improve outcome. Oncology 2004; 67:211-214.
7. Hasselblom S, Ridell B, Wedel H, et al. Testicular lymphoma. Acta Oncol 2004; 49:758-765.
8. Darby S, Hancock BW. Localized non-Hodgkin's lymphoma in the testis. Int J Cancer 2005; 26:1093-1099.
9. Avilés A, Nambo MJ, Castañeda C, et al. Rituximab and escalated chemotherapy in elderly patients woth aggressive diffuse large cell lymphoma. Cancer Biother Radiopharm 2007; 22:194-199.
10. Pfreudschuh M, Schubert J, Ziepeng M, et al. Six versus eight cycles of bi-weekly CHOP14 with or without Rituximab in elderly patients with aggressive CD20+ B-cell lymphoma. Lancet Oncol 2007; 9:105-116.
11. Autorino R, Lamendula MG, De Sio M, et al. A complete response with rituximab in metastasic diffuse large B-cell lymphoma of the testis. Int J Immunopathol Pharmacol 2007; 20:401-403.
12. Feugier P, VanHoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma. J Clin Oncol 2005; 23:4117-4126.
13. Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007; 25:579-586.
14. Vitolo U, Zucca E, Martelli M, et al. Primary diffuse large B-cell lymphoma of the testist. J Clin Oncol 2003; 21:20-27.
15. Bhatia K, Vaid AK, Gupta S, et al. Primary testicular non-Hodgkin's lymphoma. A review. Sao Paulo Med J 2007; 125:286-288.
16. Al-Abbadi MA, Hattab EM, Tarawneh S, et al. Primary testicular diffuse large Bcell lymphoma belongs to the non-germinal center B-cll like subgroup. Mod Pathol 2006; 19:1521-1527.
17. Seymour JF, Solomon B, Wolf MW, et al. Primary large non-Hodgkin's lymphoma of the testis. Clin Lymphoma 2001; 2:109-115.
18. Vitolo U, Zucca E, Martelli M, et al. Primary diffuse large B-cell lymphoma of the testis. A prospective study of Rituximab (R) -CHOP with CNS and contralateral testis prophylaxis. Blood 2006; 108:65a (Abstract 208).
19. Sarris AH, Vitolo U, Zucca E, et al. Prospective management of primary testicular lymphoma (PTL) with doxorubicin-based chemotherapy, prophylactic CNS (IT methotrexate) and radiotherapy (RT), but without Rituximab. Blood 2006; 108:695a (Abstract 2454).
20. Avilés A, Nambo MJ, Neri N, et al. Dose dense (CEOP-14) vs dose dense and rituximab (CEOP14 +R) in high-risk diffuse large cell lymphoma. Med Oncol 2007; 24:85-89.